Literature DB >> 15172443

HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.

Chiara Romagnani1, Gabriella Pietra, Michela Falco, Paola Mazzarino, Lorenzo Moretta, Maria Cristina Mingari.   

Abstract

Natural killer (NK)-cytotoxic T lymphocytes (CTL) are a subset of CD8(+) cytolytic T lymphocytes that express human leukocyte antigen (HLA) class I-specific inhibitory receptors. They are detectable as monoclonal expansions in the blood of cytomegalovirus (CMV)-seropositive individuals displaying particular HLA-Cw allotypes. Similar to NK cells, they are capable of killing various allogeneic tumor cell lines, a function referred to as "NK-like activity." The mechanism underlying this unusual functional property has recently been clarified. Via their T-cell receptor, NK-CTL recognize the nonclassical HLA class I molecule HLA-E, which is characterized by a limited polymorphism and by the ability to bind peptides derived from the leader sequence of various HLA class I alleles as well as from few viral proteins. The analysis of the T-cell receptor avidity revealed that NK-CTL recognize with high avidity a CMV UL40-derived peptide. The HLA-E-restricted recognition of CMV by NK-CTL may represent an important immunologic strategy in defenses against this virus. Indeed, unlike conventional CTL, NK-CTL mediated lysis is apparently not affected by the downregulation of major histocompatibility complex class I that occurs during CMV infection. Because the CMV UL40-derived peptide is identical to the one generated from the leader sequence of various HLA-Cw alleles, NK-CTL are also able to display an "HLA-E-dependent alloreactivity" against allogeneic target cells expressing appropriate HLA-Cw alleles. This broad ability to recognize and kill allogeneic cells may pose serious problems in transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172443     DOI: 10.1016/j.humimm.2004.02.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

1.  Extensive HLA class I allele promiscuity among viral CTL epitopes.

Authors:  Nicole Frahm; Karina Yusim; Todd J Suscovich; Sharon Adams; John Sidney; Peter Hraber; Hannah S Hewitt; Caitlyn H Linde; Daniel G Kavanagh; Tonia Woodberry; Leah M Henry; Kellie Faircloth; Jennifer Listgarten; Carl Kadie; Nebojsa Jojic; Kaori Sango; Nancy V Brown; Eunice Pae; M Tauheed Zaman; Florian Bihl; Ashok Khatri; Mina John; Simon Mallal; Francesco M Marincola; Bruce D Walker; Alessandro Sette; David Heckerman; Bette T Korber; Christian Brander
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

2.  Two class I genes of the chicken MHC have different functions: BF1 is recognized by NK cells while BF2 is recognized by CTLs.

Authors:  Taejoong Kim; Henry D Hunt; Mark S Parcells; Vicky van Santen; Sandra J Ewald
Journal:  Immunogenetics       Date:  2018-06-09       Impact factor: 2.846

Review 3.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

Review 4.  Modulation of natural killer cells by human cytomegalovirus.

Authors:  Gavin W G Wilkinson; Peter Tomasec; Richard J Stanton; Melanie Armstrong; Virginie Prod'homme; Rebecca Aicheler; Brian P McSharry; Carole R Rickards; Daniel Cochrane; Sian Llewellyn-Lacey; Eddie C Y Wang; Cora A Griffin; Andrew J Davison
Journal:  J Clin Virol       Date:  2008-03       Impact factor: 3.168

5.  A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.

Authors:  Lucy C Sullivan; Nicholas G Walpole; Carine Farenc; Gabriella Pietra; Matthew J W Sum; Craig S Clements; Eleanor J Lee; Travis Beddoe; Michela Falco; Maria Cristina Mingari; Lorenzo Moretta; Stephanie Gras; Jamie Rossjohn; Andrew G Brooks
Journal:  J Biol Chem       Date:  2017-09-25       Impact factor: 5.157

Review 6.  Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?

Authors:  Anne Halenius; Carolin Gerke; Hartmut Hengel
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

7.  The genetic contribution of HLA-E*01:03 and HLA-E*01:03-G*01:01 to Posner-Schlossman syndrome in southern Chinese.

Authors:  Xiaosheng Huang; Yunping Xu; Wenchieh Chen; Tianhui Zhu; Liumei He; Songxing Wang; Shiming Peng; Shaoyi Mei; Yan Wang; Jun Zhao
Journal:  Ann Transl Med       Date:  2019-12

8.  Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients.

Authors:  Pernille B Jørgensen; Astrid H Livbjerg; Hans J Hansen; Thor Petersen; Per Höllsberg
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

9.  Various hypotheses on MHC evolution suggested by the concerted evolution of CD94L and MHC class Ia molecules.

Authors:  Etienne Joly
Journal:  Biol Direct       Date:  2006-01-31       Impact factor: 4.540

10.  CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.

Authors:  Emma J Petrie; Craig S Clements; Jie Lin; Lucy C Sullivan; Darryl Johnson; Trevor Huyton; Annie Heroux; Hilary L Hoare; Travis Beddoe; Hugh H Reid; Matthew C J Wilce; Andrew G Brooks; Jamie Rossjohn
Journal:  J Exp Med       Date:  2008-03-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.